scholarly article | Q13442814 |
P2093 | author name string | W Y Tsai | |
L Kuhn | |||
H M Coovadia | |||
Z A Stein | |||
A Coutsoudis | |||
R A Bobat | |||
P2860 | cites work | Maternal vitamin A deficiency and mother-to-child transmission of HIV-1 | Q28237660 |
High dose vitamin A supplementation of breast-feeding Indonesian mothers: effects on the vitamin A status of mother and infant | Q28267703 | ||
Longitudinal data analysis for discrete and continuous outcomes | Q29547235 | ||
An overview of methods for the analysis of longitudinal data | Q30894816 | ||
Influence of HIV infection on vitamin status and requirements | Q35534498 | ||
Childhood mortality after a high dose of vitamin A in a high risk population | Q35820491 | ||
Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV | Q36849831 | ||
Pathogenesis of infection with human immunodeficiency virus | Q39659930 | ||
Vitamin A supplementation in infectious diseases: a meta-analysis | Q40338371 | ||
Micronutrient utilisation during measles treated with vitamin A or placebo | Q41149202 | ||
Specific nutrient abnormalities in asymptomatic HIV-1 infection | Q44033445 | ||
Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection | Q45775886 | ||
A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants | Q46394388 | ||
On the use of the quasi-likelihood method in teratological experiments. | Q52881871 | ||
Vitamin A supplementation enhances specific IgG antibody levels and total lymphocyte numbers while improving morbidity in measles | Q53848152 | ||
Vitamin A supplementation reduces measles morbidity in young African children: a randomized, placebo-controlled, double-blind trial. | Q53854573 | ||
Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil | Q56787126 | ||
A randomized, controlled trial of vitamin A in children with severe measles | Q68522034 | ||
T helper cell defect related to severity in measles | Q70035199 | ||
Vitamin A supplementation and child mortality. A meta-analysis | Q70544161 | ||
Vitamin A supplementation in northern Ghana: effects on clinic attendances, hospital admissions, and child mortality. Ghana VAST Study Team | Q72223485 | ||
Diarrheal morbidity during the first 2 years of life among HIV-infected infants | Q72743044 | ||
P433 | issue | 8 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vitamin | Q34956 |
vitamin A | Q18225 | ||
P304 | page(s) | 1076-1081 | |
P577 | publication date | 1995-08-01 | |
P1433 | published in | American Journal of Public Health | Q4744266 |
P1476 | title | The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women | |
P478 | volume | 85 |
Q36004865 | A.S.P.E.N. clinical guidelines: nutrition support of children with human immunodeficiency virus infection |
Q95643468 | Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy |
Q38098482 | Better drug therapy for the children of Africa: current impediments to success and potential strategies for improvement |
Q35578711 | Conceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS. |
Q45946879 | Dental considerations for the paediatric AIDS/HIV patient. |
Q52846962 | Effect of CD4+ lymphocyte count, viral load, and duration of taking antiretroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS |
Q41017135 | Effect of Nutrition Supplementation in Children Living with HIV at ART Centre |
Q33948636 | Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial |
Q43947810 | Effect of vitamin supplementation to HIV-infected pregnant women on the micronutrient status of their infants |
Q33937157 | Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes |
Q34609629 | Effects of vitamins, including vitamin A, on HIV/AIDS patients |
Q43942017 | Growth and micronutrient disturbances in stable, HIV-infected children in Cape Town |
Q35270757 | Impact of HIV-1 infection in South Africa |
Q33810830 | Improving child health: the role of research |
Q33927655 | Malnutrition, morbidity and mortality in children and their mothers. |
Q35029241 | Maternal multivitamin supplementation reduces the risk of diarrhoea among HIV-exposed children through age 5 years |
Q24197503 | Micronutrient supplementation for children with HIV infection |
Q24235504 | Micronutrient supplementation in children and adults with HIV infection |
Q24245608 | Micronutrient supplementation in children and adults with HIV infection |
Q33704002 | Micronutrients and the pathogenesis of human immunodeficiency virus infection |
Q36023805 | Mother-to-child transmission of human immunodeficiency virus type 1. |
Q36933747 | Nutrition and HIV/AIDS in infants and children in South Africa: implications for food-based dietary guidelines |
Q34574291 | Options for prevention of HIV transmission from mother to child, with a focus on developing countries |
Q24234778 | Prevention of diarrhoea in children with HIV infection or exposure to maternal HIV infection |
Q43952456 | Rationale and design of the Tanzania Vitamin and HIV Infection Trial |
Q38885081 | Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus |
Q37349106 | Retinoic acid and polyriboinosinic:polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations |
Q54560299 | Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-alpha from LPS-stimulated monocytes/macrophages. |
Q36509253 | Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages |
Q33785650 | Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication |
Q42222660 | Role of multivitamins, micronutrients and probiotics supplementation in management of HIV infected children |
Q46465741 | Serum beta-carotene deficiency in HIV-infected children. |
Q40240821 | Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages |
Q30432191 | The inter-relation of maternal immune competence, HIV-1 viral load, and nutritional status in preventing vertical transmission: an alternative to chemoprophylaxis? |
Q33798968 | Vitamin A and immunity to viral, bacterial and protozoan infections. |
Q35173888 | Vitamin A and infancy. Biochemical, functional, and clinical aspects |
Q33962584 | Vitamin A deficiency during pregnancy of HIV infected and non-infected women in tropical settings of Northwest Ethiopia |
Q24242761 | Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age |
Q35228891 | Vitamin A levels and human immunodeficiency virus load in injection drug users |
Q56832076 | Vitamin A supplementation and HIV-1 mother-to-child transmission in Africa |
Q71933667 | Vitamin A supplementation and morbidity in children born to HIV-infected women |
Q24234927 | Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection |
Q24245896 | Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection |
Q40053700 | Vitamin A supplements for reducing mother-to-child HIV transmission |
Q41736672 | Xerophthalmia and vitamin A status |
Search more.